The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Place of Cabergoline in Acromegaly: A Meta-Analysis
Abstract
Context: Cabergoline is widely considered to be poorly effective in acromegaly. Objective: The aim of this study was to obtain a more accurate picture of the efficacy of cabergoline in acromegaly, both alone and in combination with somatostatin analogs. Design: We systematically reviewed all trials of cabergoline therapy for acromegaly published up to 2009 in four databases (PubMed, Pascal, Embase, and Google Scholar). We identified 15 studies (11 prospective) with a total of 237 patients; none were randomized or placebo-controlled. A meta-analysis was conducted on individual data (n = 227). Results: Cabergoline was used alone in nine studies. Fifty-one (34%) of the 149 patients achieved normal IGF-I levels. In multivariate analysis, the decline in IGF-I was related to the baseline IGF-I concentration (β = 1.16; P <0.001), treatment duration (β = 0.28; P < 0.001), and baseline prolactin concentration (β = −0.18; P = 0.01), and with a trend toward a relation with the cabergoline dose (β = 0.38; P =0.07). In five studies, cabergoline was added to ongoing somatostatin analog treatment that had failed to normalize IGF-I. Forty patients (52%) achieved normal IGF-I levels. The change in IGF-I was significantly related to the baseline IGF-I level (β = 0.74; P < 0.001) but not to the dose of cabergoline, the duration of treatment, or the baseline prolactin concentration. Conclusion: This meta-analysis suggests that cabergoline single-agent therapy normalizes IGF-I levels in one third of patients with acromegaly. When a somatostatin analog fails to control acromegaly, cabergoline adjunction normalizes IGF-I in about 50% of cases. This effect may occur even in patients with normoprolactinemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Melmed, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062453 · Cited by 1,160
Criteria for Cure of Acromegaly: A Consensus Statement
Giustina, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.526 · Cited by 987
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000) · Science · doi:10.1126/science.288.5463.154 · Cited by 888
Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease
Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054830 · Cited by 884
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
A Consensus on Criteria for Cure of Acromegaly
Giustina, A., Chanson, P., Bronstein, M. D., Klibanski, A., Lamberts, S., Casanueva, F. F., Trainer, P., Ghigo, E., Ho, K., & Melmed, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2670 · Cited by 783
Self-citationDopamine Agonists and the Risk of Cardiac-Valve Regurgitation
Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., & Garbe, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062222 · Cited by 718
Mortality in Acromegaly: A Metaanalysis
Dekkers, O. M., Biermasz, N. R., Pereira, A. M., Romijn, J. A., & Vandenbroucke, J. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1191 · Cited by 517
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’
Nomikos, P., Buchfelder, M., & Fahlbusch, R. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01863 · Cited by 500
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
Holdaway, I. M., Bolland, M. J., & Gamble, G. D. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0267 · Cited by 462
Long-Acting Somatostatin Analog Therapy of Acromegaly: A Meta-Analysis
Freda, P. U., Katznelson, L., van der Lely, A. J., Reyes, C. M., Zhao, S., & Rabinowitz, D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0260 · Cited by 346
Diagnosis and Initial Management of Parkinson's Disease
Nutt, J. G., & Wooten, G. F. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp043908 · Cited by 338
Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine
Besser, G. M., Parke, L., Edwards, C. R. W., Forsyth, I. A., & McNeilly, A. S. (1972) · BMJ · doi:10.1136/bmj.3.5828.669 · Cited by 318
Schlechte, J. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp025334 · Cited by 258
Di Sarno, A., Landi, M. L., Cappabianca, P., Di Salle, F., Rossi, F. W., Pivonello, R., Di Somma, C., Faggiano, A., Lombardi, G., & Colao, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8054 · Cited by 247
Treatment of Acromegaly with Dopamine Agonists
Jaffe, C. A., & Barkan, A. L. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30210-x · Cited by 220
Barrande, G., Pittino-Lungo, M., Coste, J., Ponvert, D., BERTAGNA, X. Y., LUTON, J. P., & Bertherat, J. Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3779 · Cited by 216
A Critical Analysis of Pituitary Tumor Shrinkage during Primary Medical Therapy in Acromegaly
Melmed, S., Sternberg, R., Cook, D., Klibanski, A., Chanson, P., Bonert, V., Vance, M. L., Rhew, D., Kleinberg, D., & Barkan, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2466 · Cited by 215
Self-citationMurray, R. D., & Melmed, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0027 · Cited by 214
Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients
Ono, M., Miki, N., Kawamata, T., Makino, R., Amano, K., Seki, T., Kubo, O., Hori, T., & Takano, K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2758 · Cited by 191
Increased Prevalence of Regurgitant Valvular Heart Disease in Acromegaly
Pereira, A. M., van Thiel, S. W., Lindner, J. R., Roelfsema, F., van der Wall, E. E., Morreau, H., Smit, J. W. A., Romijn, J. A., & Bax, J. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030849 · Cited by 170
Effect of Different Dopaminergic Agents in the Treatment of Acromegaly
Colao, A. A. L., Ferone, D., Marzullo, P., Sarno, A. D., Cerbone, G., Sarnacchiaro, F., Cirillo, S., Merola, B., & Lombardi, G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3648 · Cited by 156
Colao, A., Spinelli, L., Marzullo, P., Pivonello, R., Petretta, M., Somma, C. D., Vitale, G., Bonaduce, D., & Lombardi, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021099 · Cited by 154
Characterization ofgsp-Mediated Growth Hormone Excess in the Context of McCune-Albright Syndrome
Akintoye, S. O., Chebli, C. M., Booher, S. L., Feuillan, P., Kushner, H., LeRoith, D., Cherman, N., Bianco, P., Wientroub, S., Robey, P. G., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-012022 · Cited by 152
Chanson, P., Salenave, S., Kamenický, P., Cazabat, L., & Young, J. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.05.010 · Cited by 151
Self-citationRains, C. P., Bryson, H. M., & Fitton, A. (1995) · Drugs · doi:10.2165/00003495-199549020-00009 · Cited by 142
Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients
Muratori, M., Arosio, M., Gambino, G., et al. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03348016 · Cited by 129
Potential Cardiac Valve Effects of Dopamine Agonists in Hyperprolactinemia
Valassi, E., Klibanski, A., & Biller, B. M. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2095 · Cited by 129
Octreotide Long-Acting Release (LAR)
Gillis, J. C., Noble, S., & Goa, K. L. (1997) · Drugs · doi:10.2165/00003495-199753040-00009 · Cited by 125
Dopamine D2 Receptor Gene Expression in Human Adenohypophysial Adenomas
Ştefăneanu, L., Kovács, K., Horváth, É., Buchfelder, M., Fahlbusch, R., & Lancranjan, I. (2001) · Endocrine · doi:10.1385/endo:14:3:329 · Cited by 97
Sherlock, M., Fernandez-Rodriguez, E., Alonso, A. A., Reulen, R. C., Ayuk, J., Clayton, R. N., Holder, G., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1420 · Cited by 74
Octreotide Long-Acting Release (LAR): A Review of its Use in the Management of Acromegaly
McKeage, K., Cheer, S. M., & Wagstaff, A. J. (2003) · Drugs · doi:10.2165/00003495-200363220-00014 · Cited by 72
Selvarajah, D., Webster, J., Ross, R. J. M., & Newell-Price, J. D. C. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01888 · Cited by 70
Ferrari, G. C., PARACCHI, A., Romano, C., Gerevini, G., Boghen, M. F., Barreca, A., FORTINI, P., & Dubini, A. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03695.x · Cited by 57
Growth hormone excess with onset in adolescence: clinical appearance and long‐term treatment outcome
Colao, A., Pivonello, R., Somma, C. D., Tauchmanovà, L., Savastano, S., & Lombardi, G. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02809.x · Cited by 37
Eficácia da cabergolina no tratamento da acromegalia
Vilar, L., Naves, L. A., Freitas, M. D. C., Oliveira, S., & Lyra, R. (2002) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302002000300009 · Cited by 6
Cited by
Acromegaly: An Endocrine Society Clinical Practice Guideline
Katznelson, L., Laws, E. R., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2700 · Cited by 1,786
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Diagnosis and Treatment of Pituitary Adenomas: A Review
Molitch, M. E. (2017) · JAMA · doi:10.1001/jama.2016.19699 · Cited by 933
A Consensus Statement on acromegaly therapeutic outcomes
Melmed, S., Bronstein, M. D., Chanson, P., Klibanski, A., Casanueva, F. F., Wass, J. A. H., Strasburger, C. J., Luger, A., Clemmons, D. R., & Giustina, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0058-5 · Cited by 561
Self-citation
Metadata
- Authors
- Sandret, L., Maison, P., & Chanson, P.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-05-01
- Volume
- 96
- Issue
- 5
- Pages
- 1327-1335
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1993154503
- Cited by
- 314
- References
- 38
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.